While the majority of COPD patients have EFL, care teams have never had a COPD NIV ventilation therapy that dynamically and automatically targets EFL. BiPAP A40 EFL is the first and only NIV therapy precision-crafted to abolish EFL in hypercapnic COPD patients. It screens, detects and auto-optimizes pressure – to treat comfortably and redefine what is possible in managing COPD.
Pressure (min to max) |
|
---|---|
BiPAP A40 EFL Modes |
|
Ventilation Features |
|
Trigger Type |
|
Breath Rate |
|
Inspiratory Time |
|
Low Flow O2 |
|
Settable Alarms |
|
Humidification |
|
Dimensions |
|
Weight |
|
---|---|
AC Voltage Source |
|
DC Power Source |
|
Sound |
|
For a complete list of specifications |
|
Pressure (min to max) |
|
---|---|
BiPAP A40 EFL Modes |
|
Weight |
|
---|---|
AC Voltage Source |
|
Pressure (min to max) |
|
---|---|
BiPAP A40 EFL Modes |
|
Ventilation Features |
|
Trigger Type |
|
Breath Rate |
|
Inspiratory Time |
|
Low Flow O2 |
|
Settable Alarms |
|
Humidification |
|
Dimensions |
|
Weight |
|
---|---|
AC Voltage Source |
|
DC Power Source |
|
Sound |
|
For a complete list of specifications |
|
You are about to visit a Philips global content page
ContinueSvetainė skirta tik asmenims, naudojantiems medicinos priemones profesinėje veikloje, įskaitant sveikatos priežiūros specialistams, profesinę veiklą vykdantiems asmenims, atstovaujantiems sveikatos priežiūros įstaigą ar medicinos priemonėmis prekiaujančią organizaciją.
Ar esate asmuo, atitinkantis aukščiau nurodytus kriterijus?